HyprView Information

HyprView addresses the critical limits of current predictive biomarkers in oncology, where relying solely on genes and proteins fails to accurately match patients to precision therapies. The core innovation is a proprietary and patented imaging platform combining advanced photonics and AI to achieve unmatched data quality for a better patient stratification. From raw biopsies, we capture massive amount of information and apply deep learning to this unique data set to build comprehensive biomarker signatures for predicting therapy response.